Q1 2025 Earnings Call Transcript April 22, 2025 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $1.81, ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Barclays analyst Matt Miksic maintained a Buy rating on Intuitive Surgical (ISRG – Research Report) today and set a price target of $635.00.

Intuitive Surgical is the world’s leading robotic surgery company, and it has a solid earnings track record. The company ...

Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new ...

Intuitive Surgical reported first-quarter revenue of $2.25 billion, beating analyst estimates of $2.19 billion, according to Benzinga Pro. The robotic-assisted surgery company reported first-quarter ...

While Intuitive is still reporting steady growth in the placement of its da Vinci surgical robots—as well as the number of ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

Medical device maker Intuitive Surgical said on Tuesday that U.S. tariffs will increasingly weigh on its business for the rest of the year, disrupting operations in China and potentially eroding its ...

Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...

Intuitive Surgical (ISRG) reports a robust Q1 2025 with a 19% revenue boost, da Vinci 5 growth, and updated procedure forecasts.

Intuitive leaders Gary Guthart, Dave Rosa and Jamie Samath discuss supply chain and pricing strategies in the face of new ...